Diabetes news - NicOx to move NCX 4016 forward in phase 2 for diabetes 

July 26, 2006. SophiaAntipolis, France. www.nicox.com Diabetes Supply

A large-scale head-to-head study has shown that Novartis Neoral and the widely used tacrolimus have equivalent efficacy in preventing organ rejection in kidney transplant patients, but those treated with Neoral had a significantly lower incidence of new-onset diabetes. Diabetes Supply

Type 2 diabetes before age 20 leads to a high risk of kidney disease and death by middle age, researchers said. Diabetes Supply

NZNO wants a national expert taskforce established to tackle obesity and type 2 diabetes. Diabetes Supply

This entry was posted on Thursday, July 27th, 2006 at 3:00 am and is filed under Heart Disease. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.

Related Articles

• Diabetes news - Diabetes Camp at Cedar Crest College
• Diabetes update - America, SuperSize at Your Own Peril
• Diabetes news - Researchers find drug for diabetes yields prevention
• Diabetes - Mannose-Binding Lectin and Mortality in Type 2 Diabetes
• Diabetes news - ConjuChem Biotechnologies stock rises almost 29 per cent on positive study results